Biologics Drug Development & Manufacturing

Biologics drug development involves creating therapeutic proteins or antibodies, moving them through discovery, optimization, and early safety testing before clinical evaluation.

Biologics drug substance development covers formulation, stability assessment, and preparation of a drug for clinical or commercial use.

Abzena provides end-to-end expertise across discovery, lead optimization, developability, and manufacturing to streamline the biologic drug development process.

Biologics drug substance manufacturing includes cGMP production, analytical testing, process characterization, and release activities needed for clinical through commercial supply.